H шаблоны для php fusion 7



Jan 2016. A novel acquired ALK F1245C mutation confers resistance to crizotinib in ALK -positive NSCLC but is sensitive to ceritinib. The rate of these reactions is very low due to very small cross-sections, or because the number of reacting particles is so low that any reactions that might happen are statistically insignificant.

Похожие записи: